Cordyceps Sunshine Biotech Holdings (RAJAF) Receivables - Other (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Receivables - Other history runs 5 years deep, the most recent figure standing at $5068.0 for Q4 2025.

• In Q4 2025, Receivables - Other changed N/A year-over-year to $5068.0; the TTM figure through Dec 2025 stood at $5068.0 (changed N/A YoY), while the FY2025 annual figure was $5068.0, changed N/A from the prior year.
• Receivables - Other was $5068.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $2442.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $21869.0 in Q3 2023 to a low of $2442.0 in Q4 2023.
• Historically, Receivables - Other has averaged $11071.4 across 4 years, with a median of $9502.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Receivables - Other tumbled 93.17% in 2021, then sank 42.33% in 2022.
• A 4-year view of Receivables - Other shows it stood at $16476.0 in 2021, then tumbled by 42.33% to $9502.0 in 2022, then plunged by 74.3% to $2442.0 in 2023, then soared by 107.53% to $5068.0 in 2025.
• The last three Receivables - Other figures came in at $5068.0 (Q4 2025), $2442.0 (Q4 2023), and $21869.0 (Q3 2023), per Business Quant data.